Detalhe da pesquisa
1.
Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
Kidney Int
; 89(1): 95-104, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26489025
2.
Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.
Am J Nephrol
; 43(1): 20-31, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26881752
3.
Low Bone Turnover in Chronic Kidney Disease Is Associated with Decreased VEGF-A Expression and Osteoblast Differentiation.
Am J Nephrol
; 41(6): 464-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26228644
4.
Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease.
Bone
; 173: 116808, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207990
5.
Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease.
Bone
; 157: 116340, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085840
6.
Cortical porosity occurs at varying degrees throughout the skeleton in rats with chronic kidney disease.
Bone Rep
; 17: 101612, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36035656
7.
Prenatal and Postnatal Sonographic Confirmation of Congenital Absence of the Ductus Venosus in a Child with Noonan Syndrome.
Case Rep Radiol
; 2017: 3068178, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057136
8.
Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
PLoS One
; 12(8): e0181750, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28793321
9.
Assessing the inter- and intra-animal variability of in vivo OsteoProbe skeletal measures in untreated dogs.
Bone Rep
; 5: 192-198, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27588301
10.
Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.
J Bone Miner Res
; 30(3): 499-509, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407607
11.
Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions.
Bone
; 77: 50-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892482
12.
In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs.
J Bone Miner Res
; 30(8): 1441-4, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25644867
13.
Variability of in vivo reference point indentation in skeletally mature inbred rats.
J Biomech
; 47(10): 2504-7, 2014 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24856912
14.
A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.
J Bone Miner Res
; 29(4): 902-10, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038306
15.
Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease.
PLoS One
; 9(6): e99262, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24911162
16.
In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.
Bone
; 56(2): 449-53, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871851
17.
The positive influence of state agricultural marketing programs on adults' fruit and vegetable consumption.
Am J Health Promot
; 27(1): 17-20, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22950921
18.
Raloxifene neutralizes bone brittleness induced by anti-remodeling treatment and increases fatigue life through non-cell mediated mechanisms / El raloxifeno invierte fragilidad ósea inducida por el tratamiento anti-remodelación y aumenta la resistencia a la fatiga a través de mecanismos mediados no celulares
Actual. osteol
; 12(3): 169-179, 2016. graf, tab
Artigo
em Inglês
| LILACS, UNISALUD, BINACIS | ID: biblio-1370677